Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YD01-2022 in diabetes after total pancreatectomy
NCT05990517Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2023
- Primary completion
- Aug 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of YD01-2022 in postpancreatectomy diabetes mellitus, sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
YD01-2022
03
Conditions
postpancreatectomy diabetes mellitus
Beyond the preview
Go deeper on NCT05990517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990517.